FindTrial
Sign In

The effect of lactotripeptides ingestion on vascular function in obese man

The effect of lactotripeptides ingestion on vascular function in obese man - The effect of lactotripeptides ingestion on vascular function in obese man

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032488
Enrollment
50
Registered
2018-06-01
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Lactotripeptides ingestion (4.8 mg/d), 12 weeks Placebo ingestion, 12 weeks

Sponsors

University of Tsukuba
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: BMI range: 25.0-34.9 kg/m2

Exclusion criteria

Exclusion criteria: Have a cardiovascular and cerebrovascular disease, lactose intolerance

Design outcomes

Primary

MeasureTime frame
[Before and after the 12-week intervention] - Arterial function—

Countries

Japan

Contacts

Public ContactKoichiro Tanahashi

University of Tsukuba Faculty of Health and Sport Sciences

kouichita0305@yahoo.co.jp029-853-5990

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026